drugset / Trial / NCT06524531

Pulsed RF Neuromodulation and Leukocyte-Rich PRP for Refractory Low Back Pain

NCT06524531 ↗

Phase 0 Recruiting 100 enrolled Iffat Anwar Medical Complex
RandomizedCrossoverSingle-blindTreatment

Summary

This clinical trial aims to check the safety and efficacy profile of pulsed radiofrequency (RF) neuromodulation combined with leukocyte-rich platelet-rich plasma (PRP) injections for the treatment of refractory low back pain due to multifidus dysfunction. The trial will compare two groups: one receiving standard physical therapy and the other receiving pulsed RF neuromodulation and physiotherapy.

Timeline

Start
2024-07-10
Primary completion
2025-07-10
Completion
2025-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Leukocyte-Rich PRP Unknown — Intramuscular